{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:00:08Z","timestamp":1753520408602},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,5,2]],"date-time":"2010-05-02T00:00:00Z","timestamp":1272758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00417-010-1379-9","type":"journal-article","created":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T05:48:05Z","timestamp":1272692885000},"page":"1187-1192","source":"Crossref","is-referenced-by-count":27,"title":["Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?"],"prefix":"10.1007","volume":"248","author":[{"given":"Sibylle","family":"Winterhalter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Severing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Stammen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Karina","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erhard","family":"Godehardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia Maria","family":"Joussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,2]]},"reference":[{"key":"1379_CR1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/archopht.1952.00920010132001","volume":"48","author":"HC Wilder","year":"1952","unstructured":"Wilder HC (1952) Toxoplasma chorioretinitis in adults. Arch Ophthalmol 48:127\u2013136","journal-title":"Arch Ophthalmol"},{"key":"1379_CR2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","volume":"115","author":"A Rothova","year":"1993","unstructured":"Rothova A, Meenken C, Buitenhuis HJ (1993) Therapy for ocular toxoplasmosis. Am J Ophthalmol 115:517\u2013523","journal-title":"Am J Ophthalmol"},{"key":"1379_CR3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archopht.1964.00970010074010","volume":"71","author":"TE Acers","year":"1964","unstructured":"Acers TE (1964) Toxoplasmic retinochoroiditis: a double-blind therapeutic study. Arch Ophthalmol 71:58\u201362","journal-title":"Arch Ophthalmol"},{"key":"1379_CR4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0161-6420(03)00083-6","volume":"110","author":"MR Stanford","year":"2003","unstructured":"Stanford MR, See SE, Jones LV (2003) Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systemic review. Ophthalmology 110:926\u2013931","journal-title":"Ophthalmology"},{"key":"1379_CR5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ajo.2003.09.040","volume":"136","author":"GN Holland","year":"2003","unstructured":"Holland GN, O\u2019Connor G, Belfort R Jr, Remington JS (2003) Ocular toxoplasmosis: a global reassessment. Part I: Epidemiology and course of disease. Am J Ophthalmol 136:973\u2013988","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"1379_CR6","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/bjo.2007.123661","volume":"92","author":"JG Garweg","year":"2008","unstructured":"Garweg JG, Scherrer JN, Halberstad M (2008) Recurrence characteristics in European patients with ocular toxoplasmosis. BJO 92(9):1253\u20131256","journal-title":"BJO"},{"issue":"5","key":"1379_CR7","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0161-6420(02)00990-9","volume":"109","author":"L Bosch-Driessen","year":"2002","unstructured":"Bosch-Driessen L, Berendschot T, Ongkosuwito J, Rothova A (2002) Ocular toxoplasmosis\u2014clinical features and prognosis of 154 patients. Ophthalmology 109(5):869\u2013878","journal-title":"Ophthalmology"},{"key":"1379_CR8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/infdis\/164.1.170","volume":"164","author":"J Huskinson-Mark","year":"1991","unstructured":"Huskinson-Mark J, Araujo FG, Remington JS (1991) Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J Infect Dis 164:170\u2013177","journal-title":"J Infect Dis"},{"key":"1379_CR9","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/bjo.82.11.1306","volume":"82","author":"A Rothova","year":"1998","unstructured":"Rothova A, Bosch-Driessen E, van Loon NH, Treffers WF (1998) Azithromycin for ocular toxoplasmosis. Br J Ophthalmol 82:1306\u20131308","journal-title":"Br J Ophthalmol"},{"key":"1379_CR10","first-page":"1171","volume":"39","author":"PD Gormley","year":"1998","unstructured":"Gormley PD, Pavesio CE, Minnasian D, Lightman S (1998) Effects of drug therapy on toxoplasma cysts in an animal model of acute and chronic disease. Invest Ophthalmol Vis Sci 39:1171\u20131175","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1379_CR11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0161-6420(99)90021-0","volume":"106","author":"PA Pearson","year":"1999","unstructured":"Pearson PA, Piracha AR, Sen HA, Jaffe GJ (1999) Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology 106(1):148\u2013153","journal-title":"Ophthalmology"},{"key":"1379_CR12","first-page":"1183","volume-title":"Ocular infection and immunity","author":"GN Holland","year":"1996","unstructured":"Holland GN, O\u2019Connor GR, Belfort R Jr, Remington JS (1996) Ocular infection and immunity. Mosby-Year Book, St. Louis, pp 1183\u20131223"},{"issue":"6","key":"1379_CR13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ajo.2008.01.023","volume":"145","author":"G Holland","year":"2008","unstructured":"Holland G, Crespi CM, Dam-van Loon N et al (2008) Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. Am J Ophthalmol 145(6):1007\u20131013","journal-title":"Am J Ophthalmol"},{"key":"1379_CR14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10792-007-9047-8","volume":"26","author":"I Tugal-Tutkun","year":"2005","unstructured":"Tugal-Tutkun I, Corum I, \u00d6t\u00fck B, Urgancioglu M (2005) Active ocular toxoplasmosis in Turkish patients: a report on 109 cases. Int Ophthalmol 26:221\u2013228","journal-title":"Int Ophthalmol"},{"key":"1379_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2125.1994.tb04232.x","volume":"37","author":"PE Rolan","year":"1994","unstructured":"Rolan PE, Mercer AJ, Weatherley BC (1994) Examination of some factors responsible for a food-induced increase in absorption of atovaquone. Br J Clin Pharmacol 37:13\u201320","journal-title":"Br J Clin Pharmacol"},{"key":"1379_CR16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00347-007-1535-8","volume":"104","author":"U Pleyer","year":"2007","unstructured":"Pleyer U, Torun N, Liesenfeld O (2007) Okul\u00e4re Toxoplasmose. Der Ophthalmologe 104:603\u2013616","journal-title":"Der Ophthalmologe"},{"issue":"8","key":"1379_CR17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bjo.82.8.858","volume":"82","author":"EH Bosch-Driessen","year":"1998","unstructured":"Bosch-Driessen EH, Rothova A (1998) Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis. Br J Ophthalmol 82(8):858\u2013860","journal-title":"Br J Ophthalmol"},{"key":"1379_CR18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/infdis\/155.3.550","volume":"155","author":"JM Hofflin","year":"1987","unstructured":"Hofflin JM, Conley FK, Remington JS (1987) Murine model of intracerebral toxoplasmosis. J Infect Dis 155:550\u2013556","journal-title":"J Infect Dis"},{"issue":"4","key":"1379_CR19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000078612","volume":"218","author":"OM Durrani","year":"2004","unstructured":"Durrani OM, Meeds CA, Murray PI (2004) Uveitis: a potentially blinding disease. Opththalmologica 218(4):223\u2013236","journal-title":"Opththalmologica"},{"key":"1379_CR20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-2008-1045914","volume":"201","author":"HG Krumpaszky","year":"1992","unstructured":"Krumpaszky HG, Klau\u00df V, Kloske G (1992) Soziale Kosten von Sehbehinderung und Blindheit. Rehabilitationsangebot f\u00fcr die Betroffenen Klin Mbl Augenheilk 201:370\u2013374","journal-title":"Rehabilitationsangebot f\u00fcr die Betroffenen. Klin Mbl Augenheilk"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1379-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-010-1379-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1379-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:40:55Z","timestamp":1559072455000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-010-1379-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,2]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1007\/s00417-010-1379-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,2]]}}}